Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2025 Volume 30 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2025 Volume 30 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study

  • Authors:
    • Jin Kuang
    • Qian Rao
    • Zhigang Cheng
  • View Affiliations / Copyright

    Affiliations: Department of Stomatology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China, Department of Stomatology, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China
    Copyright: © Kuang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 170
    |
    Published online on: July 8, 2025
       https://doi.org/10.3892/etm.2025.12920
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Parotid gland tumors (PGTs) are the most common salivary gland neoplasms, encompassing diverse benign and malignant pathologies. Accurate preoperative diagnosis is vital for surgical planning, functional outcomes (e.g., facial nerve preservation), and prognosis. While histopathology remains the gold standard, non‑invasive imaging, such as ultrasound (US) and MRI, plays a critical role in initial tumor characterization. US is widely used due to its accessibility and cost‑effectiveness, but its utility is constrained by acoustic limitations and operator dependence. MRI, with superior soft tissue contrast and multiplanar capabilities, excels in delineating tumor extent and neural involvement but often struggles to differentiate benign from malignant lesions due to overlapping imaging features. The comparisons of diagnostic performance between US and MRI limited, and optimal imaging parameters for specific PGT subtypes remain underinvestigated. The aim of the present study was to review and summarize the clinical presentations and histological types of parotid tumors, whilst also evaluating the diagnostic accuracy of US and MRI, to determine optimal US imaging parameters for pleomorphic adenomas and Warthin tumors. The medical records, including imaging examination results, type of parotidectomy and postoperative pathological findings, of 214 patients with confirmed PGTs were collected from the database of Central Hospital of Wuhan (Wuhan, China). The nature of the tumor was assessed based on imaging findings (US and MRI), with postoperative pathology (hematoxylin and eosin and immunohistochemistry) used as the gold standard. The sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) for US and MRI were established. The area under the curve (AUC) was computed to compare the accuracy of US and MRI in identifying the nature of parotid gland tumors. The Youden index was calculated to evaluate the diagnostic power. Data analysis was conducted using SPSS version 29.0, where statistical significance was set at P<0.05 using the χ2 test. In the field of PGT diagnosis, the combination of US and MRI technologies was found to significantly enhance diagnostic precision. This integrated approach showed a statistically significant improvement over the use of US alone (P<0.05). Although MRI, as an independent modality, showed higher accuracy compared with that of US, the difference between MRI and US was not statistically significant. The receiver operating characteristic curve analysis indicated that the AUC for MRI in diagnosing benign and malignant parotid gland tumors was 0.899, which was significantly greater compared with that of US (0.702; P<0.001). The combined diagnosis using US and MRI achieved the highest specificity (94.8%), compared with US (52.6%) and MRI (71.9%) alone. For the combined US‑MRI approach, the PPV, NPV and Youden index were 84.6, 95.0 and 0.68%. For US and MRI alone, the PPV, NPV and Youden index were 64.7, 94.1 and 0.34%, and 75.8, 95.0 and 0.67%, respectively. To conclude, these data suggest that the amalgamation of MRI and US can provide an efficacious means of diagnosing PGTs, thereby constituting an instrumentation for the preoperative qualitative evaluation of these tumors.
View Figures

Figure 1

Echogenicity and heterogeneity of
parotid gland tumors under ultrasound. (A) Slightly hypoechogenic
and slightly heterogenic pleomorphic adenoma. (B) Highly
hypoechogenic and highly heterogenic WT. (C) Highly hypoechogenic
and slightly heterogenic WT (D) Slightly hypoechogenic and highly
heterogenic mucoepidermoid carcinoma. WT, Warthin's tumor.

Figure 2

Features of malignant tumor
(mucoepidermoid carcinoma) on US, MRI and histopathology. (A) US
shows an irregularly contoured mass with indistinct margins, marked
hypoechogenicity and pronounced heterogeneity. (B) Color Doppler
demonstrates moderate intralesional vascularity (arrow). (C)
Histopathology (H&E stain): Tumor stroma with dense lymphoid
infiltration, multiple cystic formations and variably distributed
epithelial nests showing squamous differentiation, intermediate
cells and goblet cell metaplasia. (D) Coronal T2-weighted MRI:
Irregular peripheral margins with heterogeneous signal intensity
and nodular components (arrows). (E) Axial T1-weighted MRI:
Homogeneous hypointensity (relative to parotid gland parenchyma).
(F) Short Tau Inversion Recovery sequence: Diffuse signal
heterogeneity with enlarged cervical lymph nodes (arrows). US,
ultrasound.

Figure 3

Features of pleomorphic adenoma on
US, MRI and histopathology. (A) US: Regular contours,
well-circumscribed margins (arrow) and mild hypoechogenicity. (B)
Color Doppler: Homogeneous architecture without detectable
vascularity. (C) Histopathology (H&E stain): Confluent sheets
of epithelial/myoepithelial cells embedded in chondromyxoid stroma
(arrow). (D) Coronal T2-weighted MRI: Well-defined margins (arrow)
with dominant hyperintensity admixed with hypointense foci. (E)
Axial T1-weighted MRI: Heterogeneous hypointensity. (F) Short Tau
Inversion Recovery sequence: No abnormal lymph nodes (arrow). US,
ultrasound.

Figure 4

Features of Warthin's tumor on US,
MRI and histopathology. (A) US: Irregular shape, well-defined
margins (arrow), marked hypoechogenicity and mild heterogeneity.
(B) Color Doppler: Intense intratumoral vascularity (arrows). (C)
Histopathology (H&E stain): Bilayered oncocytic epithelium
forming compact tubules within lymphoplasmacytic stroma (arrow).
(D) T2-weighted MRI: Balanced proportion of hyperintense and
hypointense signals. (E) T1-weighted MRI: Heterogeneous
hypointensity with prominent cystic components (arrow). (F) Short
Tau Inversion Recovery sequence: Intralesional cystic changes
(arrow); cervical lymph nodes within normal limits (arrow). US,
ultrasound.

Figure 5

Features of a cyst on US, MRI and
histopathology. (A) US: Irregular shape, well-defined margins,
marked hypoechogenicity and moderate heterogeneity (arrow). (B)
Color Doppler: Prominent intralesional vascularity (arrow). (C)
Histopathology (H&E stain): Keratinizing stratified squamous
epithelial lining with luminal necrotic debris (arrow). (D)
T2-weighted MRI: Well-circumscribed cystic lesion with homogeneous
hyperintensity (arrow). (E) T1-weighted MRI: Entirely homogeneous
hyperintensity (no hypointense foci). (F) Short Tau Inversion
Recovery sequence: No solid enhancement (arrow) or enlarged lymph
nodes. US, ultrasound.

Figure 6

Receiver operating characteristics
curve for US and MRI. AUC are 0.702 (95% CI, 0.595-0.810), 0.899
(95% CI, 0.845-0.953) and 0.841 (95% CI, 0.743-0.938) for US, MRI
and US + MRI, respectively. The sensitivity and specificity of US
in differentiating malignant from benign tumors were 81.8 and
52.6%, respectively. The predictive values were calculated as
follows: PPV was 64.7% and negative NPV was 94.1%. The Youden Index
was 0.34. For MRI, the sensitivity and specificity were 95.5 and
71.9%, respectively. The predictive values were calculated as
follows: PPV was 75.8% and NPV was 95%. The Youden Index was 0.67.
For US + MRI, the sensitivity, specificity, PPV and NPV were 72.7,
94.8, 84.6 and 95%, respectively. This indicates a statistically
significant difference in accuracy between US and MRI, in addition
to between US + MRI and US. AUC, area under the curve, US,
ultrasound; NPV, negative predictive value; PPV, positive
predictive value.

Figure 7

Receiver operating characteristic
curves for WT and PA. Diagnostic performance metrics for
differentiating WT from PA were as follows. Hypoechogenicity:
AUC=0.694 (95% CI, 0.612-0.755); sensitivity, 79.6%; specificity,
88.2%; PPV, 67.8%; NPV, 71.2%. Homogeneity: AUC=0.619 (95% CI,
0.554-0.685); sensitivity, 57.1%; specificity, 35.7%; PPV, 69.4%;
NPV, 64.6%. Hypoechogenity and homogeneity are the most reliable
parameters for differentiating between WT and PA using ultrasound
(P<0.05). AUC, area under the curve; PPV, positive predictive
value; NPV, negative predictive value; WT, Warthin's tumors; PA,
pleomorphic adenoma.
View References

1 

Bradley PJ and McGurk M: Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg. 51:399–403. 2013.PubMed/NCBI View Article : Google Scholar

2 

Inaka Y, Kawata R, Haginomori SI, Terada T, Higashino M, Omura S and Kikuoka Y: Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: A 20-year review at a single institution. Int J Clin Oncol. 26:1170–1178. 2021.PubMed/NCBI View Article : Google Scholar

3 

Bonavolontà P, Dell'Aversana Orabona G, Maglitto F, Abbate V, Committeri U, Salzano G, Improta G, Iaconetta G and Califano L: Postoperative complications after removal of pleomorphic adenoma from the parotid gland: A long-term follow up of 297 patients from 2002 to 2016 and a review of publications. Br J Oral Maxillofac Surg. 57:998–1002. 2019.PubMed/NCBI View Article : Google Scholar

4 

Luers JC, Guntinas-Lichius O, Klussmann JP, Küsgen C, Beutner D and Grosheva M: The incidence of Warthin tumours and pleomorphic adenomas in the parotid gland over a 25-year period. Clin Otolaryngol. 41:793–797. 2016.PubMed/NCBI View Article : Google Scholar

5 

Ferreira PC, Amarante JM, Rodrigues JM, Pinho CJ, Cardoso MA and Reis JC: Parotid surgery: Review of 107 tumors (1990-2002). Int Surg. 90:160–166. 2005.PubMed/NCBI

6 

Mohammed F, Asaria J, Payne RJ and Freeman JL: Retrospective review of 242 consecutive patients treated surgically for parotid gland tumours. J Otolaryngol Head Neck Surg. 37:340–346. 2008.PubMed/NCBI

7 

Maahs GS, Oppermann Pde O, Maahs LG, Machado Filho G and Ronchi AD: Parotid gland tumors: A retrospective study of 154 patients. Braz J Otorhinolaryngol. 81:301–306. 2015.PubMed/NCBI View Article : Google Scholar

8 

Choi SY, Lee E, Kim E, Chung MK, Son YI, Baek CH and Jeong HS: Clinical outcomes of bulky parotid gland cancers: Need for self-examination and screening program for early diagnosis of parotid tumors. BMC Cancer. 21(178)2021.PubMed/NCBI View Article : Google Scholar

9 

Witt RL: Facial nerve function after partial superficial parotidectomy: An 11-year review (1987-1997). Otolaryngol Head Neck Surg. 121:210–213. 1999.PubMed/NCBI View Article : Google Scholar

10 

David E, Cantisani V, De Vincentiis M, Sidhu PS, Greco A, Tombolini M, Drudi FM, Messineo D, Gigli S, Rubini A, et al: Contrast-enhanced ultrasound in the evaluation of parotid gland lesions: An update of the literature. Ultrasound. 24:104–110. 2016.PubMed/NCBI View Article : Google Scholar

11 

Stoia S, Lenghel M, Dinu C, Tamaș T, Bran S, Băciuț M, Boțan E, Leucuța D, Armencea G, Onișor F and Băciuț G: The value of multiparametric magnetic resonance imaging in the preoperative differential diagnosis of parotid gland tumors. Cancers (Basel). 15(1325)2023.PubMed/NCBI View Article : Google Scholar

12 

Lee YY, Wong KT, King AD and Ahuja AT: Imaging of salivary gland tumours. Eur J Radiol. 66:419–436. 2008.PubMed/NCBI View Article : Google Scholar

13 

Quer M, Vander Poorten V, Takes RP, Silver CE, Boedeker CC, de Bree R, Rinaldo A, Sanabria A, Shaha AR, Pujol A, et al: Surgical options in benign parotid tumors: A proposal for classification. Eur Arch Otorhinolaryngol. 274:3825–3836. 2017.PubMed/NCBI View Article : Google Scholar

14 

McGurk M, Thomas BL and Renehan AG: Extracapsular dissection for clinically benign parotid lumps: Reduced morbidity without oncological compromise. Br J Cancer. 89:1610–1613. 2003.PubMed/NCBI View Article : Google Scholar

15 

Vander Poorten V, Jankowska P and Metcalf R: Salivary gland. In: Stell and Maran's head and neck surgery and oncology. 6th edition. CRC Press, Boca Raton, FL, 2025.

16 

Witt RL: Minimally invasive surgery for parotid pleomorphic adenoma. Ear Nose Throat J. 84:308. 310–311. 2005.PubMed/NCBI

17 

Di Santo D, Deretti A and Vander Poorten V: Current surgical management of malignant parotid tumors. Curr Opin Otolaryngol Head Neck Surg. 33:79–84. 2025.PubMed/NCBI View Article : Google Scholar

18 

Roh JL, Kim HS and Park CI: Randomized clinical trial comparing partial parotidectomy versus superficial or total parotidectomy. Br J Surg. 94:1081–1087. 2007.PubMed/NCBI View Article : Google Scholar

19 

Lombardi D, McGurk M, Vander Poorten V, Guzzo M, Accorona R, Rampinelli V and Nicolai P: Surgical treatment of salivary malignant tumors. Oral Oncol. 65:102–113. 2017.PubMed/NCBI View Article : Google Scholar

20 

Huyett P, Duvvuri U, Ferris RL, Johnson JT, Schaitkin BM and Kim S: Perineural invasion in parotid gland malignancies. Otolaryngol Head Neck Surg. 158:1035–1041. 2018.PubMed/NCBI View Article : Google Scholar

21 

Park W, Park J, Park SI, Kim H, Bae H, Cho J, Won H, Park M and Jeong HS: Clinical outcomes and management of facial nerve in patients with parotid gland cancer and pretreatment facial weakness. Oral Oncol. 89:144–149. 2019.PubMed/NCBI View Article : Google Scholar

22 

Freling NJ, Molenaar WM, Vermey A, Mooyaart EL, Panders AK, Annyas AA and Thijn CJ: Malignant parotid tumors: Clinical use of MR imaging and histologic correlation. Radiology. 185:691–696. 1992.PubMed/NCBI View Article : Google Scholar

23 

Okahara M, Kiyosue H, Hori Y, Matsumoto A, Mori H and Yokoyama S: Parotid tumors: MR imaging with pathological correlation. Eur Radiol. 13 (Suppl 4):L25–L33. 2003.PubMed/NCBI View Article : Google Scholar

24 

Gritzmann N, Rettenbacher T, Hollerweger A, Macheiner P and Hübner E: Sonography of the salivary glands. Eur Radiol. 13:964–975. 2003.PubMed/NCBI View Article : Google Scholar

25 

Andreasen S, Therkildsen MH, Bjørndal K and Homøe P: Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck. 38 (Suppl 1):E1364–E1369. 2016.PubMed/NCBI View Article : Google Scholar

26 

Moeller K, Esser D, Boeger D, Buentzel J, Hoffmann K, Jecker P, Mueller A, Radtke G, Piesold JU, Schultze-Mosgau S, et al: Parotidectomy and submandibulectomy for benign diseases in Thuringia, Germany: A population-based study on epidemiology and outcome. Eur Arch Otorhinolaryngol. 270:1149–1155. 2013.PubMed/NCBI View Article : Google Scholar

27 

Barnes L, Eveson JW, Reichart PA and Sidransky D (eds): Pathology and Genetics of Head and Neck Tumours. In: WHO Classification of Tumours. 3rd edition, Vol 9. IARC, Lyon, 2005.

28 

Takahama Junior A, Almeida OP and Kowalski LP: Parotid neoplasms: Analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol. 75:497–501. 2009.PubMed/NCBI View Article : Google Scholar

29 

Committeri U, Arena A, Iaquino V, Salzano G, Blasi FD, Esposito M, Giovacchini F, Calvanese C, Abbate V, Bonavolontà P, et al: Surgical management and side effects of parotid gland surgery for benign lesions: A retrospective analysis of our experience from 2012 to 2021. Br J Oral Maxillofac Surg. 61:411–415. 2023.PubMed/NCBI View Article : Google Scholar

30 

Lee DH, Jung EK, Lee JK and Lim SC: Comparative analysis of benign and malignant parotid gland tumors: A retrospective study of 992 patients. Am J Otolaryngol. 44(103690)2023.PubMed/NCBI View Article : Google Scholar

31 

Valstar MH, de Ridder M, van den Broek EC, Stuiver MM, van Dijk BAC, van Velthuysen MLF, Balm AJM and Smeele LE: Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol. 66:93–99. 2017.PubMed/NCBI View Article : Google Scholar

32 

Gunn A and Parrott NR: Parotid tumours: A review of parotid tumour surgery in the Northern regional health authority of the United Kingdom 1978-1982. Br J Surg. 75:1144–1146. 1988.PubMed/NCBI View Article : Google Scholar

33 

Cantisani V, David E, Sidhu PS, Sacconi B, Greco A, Pandolfi F, Tombolini M, Lo Mele L, Calliada F, Brunese L, et al: Parotid gland lesions: Multiparametric ultrasound and MRI features. Ultraschall Med. 37:454–471. 2016.PubMed/NCBI View Article : Google Scholar

34 

Rzepakowska A, Osuch-Wójcikiewicz E, Sobol M, Cruz R, Sielska-Badurek E and Niemczyk K: The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Otorhinolaryngol. 274:3231–3240. 2017.PubMed/NCBI View Article : Google Scholar

35 

Zajkowski P, Jakubowski W, Białek EJ, Wysocki M, Osmólski A and Serafin-Król M: Pleomorphic adenoma and adenolymphoma in ultrasonography. Eur J Ultrasound. 12:23–29. 2000.PubMed/NCBI View Article : Google Scholar

36 

Brennan PA, Ammar M and Matharu J: Contemporary management of benign parotid tumours - the increasing evidence for extracapsular dissection. Oral Dis. 23:18–21. 2017.PubMed/NCBI View Article : Google Scholar

37 

Cortcu S, Elmali M, Tanrivermis Sayit A and Terzi Y: The role of real-time sonoelastography in the differentiation of benign from malignant parotid gland tumors. Ultrasound Q. 34:52–57. 2018.PubMed/NCBI View Article : Google Scholar

38 

Rong X, Zhu Q, Ji H, Li J and Huang H: Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: Ultrasonographic features. Acta Radiol. 55:1203–1209. 2014.PubMed/NCBI View Article : Google Scholar

39 

Fayad LM, Carrino JA and Fishman EK: Musculoskeletal infection: Role of CT in the emergency department. Radiographics. 27:1723–1736. 2007.PubMed/NCBI View Article : Google Scholar

40 

Xu Z, Jin Y, Wu W, Wu J, Luo B, Zeng C, Guo X, Gao M, Guo S and Pan A: Machine learning-based multiparametric traditional multislice computed tomography radiomics for improving the discrimination of parotid neoplasms. Mol Clin Oncol. 15(245)2021.PubMed/NCBI View Article : Google Scholar

41 

Muntean DD, Dudea SM, Băciuț M, Dinu C, Stoia S, Solomon C, Csaba C, Rusu GM and Lenghel LM: The role of an MRI-based radiomic signature in predicting malignancy of parotid gland tumors. Cancers (Basel). 15(3319)2023.PubMed/NCBI View Article : Google Scholar

42 

Zhang R, Ai QYH, Wong LM, Green C, Qamar S, So TY, Vlantis AC and King AD: Radiomics for discriminating benign and malignant salivary gland tumors; which radiomic feature categories and MRI sequences should be used? Cancers (Basel). 14(5804)2022.PubMed/NCBI View Article : Google Scholar

43 

Karaman CZ, Tanyeri A, Özgür R and Öztürk VS: Parotid gland tumors: Comparison of conventional and diffusion-weighted MRI findings with histopathological results. Dentomaxillofac Radiol. 50(20200391)2021.PubMed/NCBI View Article : Google Scholar

44 

Koh DM and Collins DJ: Diffusion-weighted MRI in the body: Applications and challenges in oncology. AJR Am J Roentgenol. 188:1622–1635. 2007.PubMed/NCBI View Article : Google Scholar

45 

Baliyan V, Das CJ, Sharma S and Gupta AK: Diffusion-weighted imaging in urinary tract lesions. Clin Radiol. 69:773–782. 2014.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kuang J, Rao Q and Cheng Z: Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study. Exp Ther Med 30: 170, 2025.
APA
Kuang, J., Rao, Q., & Cheng, Z. (2025). Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study. Experimental and Therapeutic Medicine, 30, 170. https://doi.org/10.3892/etm.2025.12920
MLA
Kuang, J., Rao, Q., Cheng, Z."Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study". Experimental and Therapeutic Medicine 30.3 (2025): 170.
Chicago
Kuang, J., Rao, Q., Cheng, Z."Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study". Experimental and Therapeutic Medicine 30, no. 3 (2025): 170. https://doi.org/10.3892/etm.2025.12920
Copy and paste a formatted citation
x
Spandidos Publications style
Kuang J, Rao Q and Cheng Z: Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study. Exp Ther Med 30: 170, 2025.
APA
Kuang, J., Rao, Q., & Cheng, Z. (2025). Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study. Experimental and Therapeutic Medicine, 30, 170. https://doi.org/10.3892/etm.2025.12920
MLA
Kuang, J., Rao, Q., Cheng, Z."Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study". Experimental and Therapeutic Medicine 30.3 (2025): 170.
Chicago
Kuang, J., Rao, Q., Cheng, Z."Diagnostic accuracy of ultrasound and MRI in parotid gland tumors: A retrospective study". Experimental and Therapeutic Medicine 30, no. 3 (2025): 170. https://doi.org/10.3892/etm.2025.12920
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team